Assessment Of Disease Pathology And Key Therapeutic Targets In Severe Asthma
Clinical trial NCT00327197 · TERMINATED
Trial details
- NCT number
- NCT00327197
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-02
- Primary completion
- 2011-06-06
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.